RxDoctor Payments Data

Rodney Infante, MD

Gastroenterology · Dallas, TXNPI 1477817849

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $20,000 of the $25,868 with a category attached, or 77.3%. Pfizer accounts for 77.5% of it on its own, with 1 other manufacturer making up the rest. Among gastroenterology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,868in general payments, 2019–2025

Across 7 payments — averaging $3695.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$20K
  • Tanabe Pharma Corporation$6K
$416,620in research payments, 2019–2025

Across 7 payments — averaging $59,517 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$417K

What the payments were for

  • Consulting fees$20,00077%
  • Speaking & faculty fees$1,0004%
  • Travel & lodging$4,79719%
  • Food & beverage$720%

General payments by program year

22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer3$20,055
Tanabe Pharma Corporation4$5,813

How this compares

$25,868 in reported general payments places this provider in the 90th percentile of 1,350 gastroenterology providers in Texas.

See all gastroenterology providers in Texas

Medicare billing

Part B allowed, 2024
$11,264
Medicare patients
64
Services billed
90

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →